Featured event

Sun, 13 Jul 2025 - Thu, 17 Jul 2025
The 13th IAS Conference on HIV Science
IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, and virtually, from 13 to 17 July 2025. Pre-meetings will be held on 13 July.
More upcoming events

29 Apr 2025
Why opportunistic infections still matter in the HIV response - Part 1
Viewers will explore Histoplasmosis and Chagas in HIV, focusing on clinical cases and speakers’ insights.
View details View details
30 Apr 2025
Solutions at your fingertips: An innovation workshop
This innovation workshop explores ways to move ahead in the HIV response during uncertain times.
View details View details
6 May 2025 - 8 May 2025
Académie Scientifique du Vaccin contre le VIH 2025
Cette académie est spécifiquement dédiée à la promotion de l'excellence de la recherche sur les vaccins contre le VIH dans la région de l'Afrique de l'Ouest.
View details View details
7 May 2025
Why opportunistic infections still matter in the HIV response - Part 2
Viewers will explore TB Meningitis and Talaromyces marneffei in HIV, focusing on clinical cases and speakers’ insights.
View details View detailsLatest news

29 Jan 2025
IAS statement: Restore access to all PEPFAR-supported HIV services immediately
29 January 2025 (Geneva, Switzerland) – IAS – the International AIDS Society – notes the decision to waive the suspension of “life-saving humanitarian assistance”, including “core life-saving medicine.” This should now ensure that HIV treatment disbursed by the US President's Emergency Plan for AIDS Relief (PEPFAR) can continue across all PEPFAR-supported countries. The Trump administration froze foreign aid funding, including to PEPFAR and, unexpectedly on 24 January, it imposed a stop-work order on existing operations. Clinic staff were sent home, distribution of ARVs bought with US funds was halted – cutting off HIV treatment for 20.6 million people. On 28 January, new US Secretary of State Marco Rubio issued a temporary waiver of aspects of this freeze. “Since its bipartisan creation, PEPFAR has always been synonymous with saving lives and this waiver restores – in some part – that legacy. However, PEPFAR’s continued and uninterrupted support of all HIV treatment and prevention services must be fully restored,” IAS President Beatriz Grinsztejn said. “PEPFAR has been and should continue to be an active contributor to changing the trajectory of the HIV epidemic. It is our hope that this waiver remains in place and will be expanded to all HIV services.” For now, the emphasis should be on ensuring that, as a matter of urgency, PEPFAR implementers return to work to ensure that access to critical HIV services is not further interrupted and that communities most in need are able to get the care and treatment they need.
Read more IAS statement: Restore access to all PEPFAR-supported HIV services immediately
11 Apr 2025
A special spotlight on CIPHER Grantees

09 Apr 2025
What are they up to now? Stories of change of AIDS 2024 scholarship alumni

11 Feb 2025
International Day of Women and Girls in Science: A special spotlight on IAS Young Leaders
